These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38838952)

  • 21. Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.
    Han J; Li-Gao R; de Mutsert R; Rosendaal FR; van Hylckama Vlieg A
    EJHaem; 2024 Feb; 5(1):47-54. PubMed ID: 38406509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.
    Stott B; Korbelik M
    Cancer Immunol Immunother; 2007 May; 56(5):649-58. PubMed ID: 16947020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Differences and Associations Between Complement Activation and Synovial Vascularization in Patients with Late-Stage Knee Osteoarthritis.
    Sodhi EU; Philpott HT; Carter MM; Birmingham TB; Appleton CT
    Front Immunol; 2022; 13():890094. PubMed ID: 35686134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis.
    Lee N; Kim JE; Gu JY; Yoo HJ; Kim I; Yoon SS; Park S; Han KS; Kim HK
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):84-9. PubMed ID: 26203764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.
    Høiland II; Liang RA; Hindberg K; Latysheva N; Brekke OL; Mollnes TE; Hansen JB
    Thromb Res; 2018 Sep; 169():50-56. PubMed ID: 30015228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
    Hetland G; Johnson E; Aasebø U
    Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
    Hetland G; Johnson E; Falk RJ; Eskeland T
    Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity.
    Khoa DV; Wimmers K
    Asian-Australas J Anim Sci; 2015 Sep; 28(9):1354-61. PubMed ID: 26194222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.
    Mollnes TE; Storm BS; Brekke OL; Nilsson PH; Lambris JD
    Semin Immunol; 2022 Jan; 59():101604. PubMed ID: 35570131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraindividual variability over time of thrombin generation in patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Lamblin G; Talon L; Muti L; Massoulier S; Pereira B; Lebreton A; Abergel A
    J Thromb Haemost; 2023 Jun; 21(6):1441-1452. PubMed ID: 36758726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.
    Indirli R; Ferrante E; Scalambrino E; Profka E; Clerici M; Lettera T; Serban AL; Vena W; Pizzocaro A; Bonomi M; Cangiano B; Carosi G; Mazziotti G; Persani L; Lania A; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1660-e1672. PubMed ID: 33382882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin Generation in Patients With Suspected Venous Thromboembolism.
    Wexels F; Dahl OE; Pripp AH; Seljeflot I
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):416-421. PubMed ID: 28335612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.